97 related articles for article (PubMed ID: 27924889)
1. Living to 120.
Gifford B
Sci Am; 2016 Aug; 315(3):62-69. PubMed ID: 27924889
[No Abstract] [Full Text] [Related]
2. Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.
Mouchiroud L; Molin L; Dallière N; Solari F
Biofactors; 2010; 36(5):377-82. PubMed ID: 20848587
[TBL] [Abstract][Full Text] [Related]
3. New tricks from old dogs join the fight against ageing.
Savage N
Nature; 2017 Dec; 552(7684):S57-S59. PubMed ID: 29239380
[No Abstract] [Full Text] [Related]
4. TOR-inhibitors as gero-suppressors.
Nikiforov M
Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
[No Abstract] [Full Text] [Related]
5. AMP-activated protein kinase counteracts brain-derived neurotrophic factor-induced mammalian target of rapamycin complex 1 signaling in neurons.
Ishizuka Y; Kakiya N; Witters LA; Oshiro N; Shirao T; Nawa H; Takei N
J Neurochem; 2013 Oct; 127(1):66-77. PubMed ID: 23841933
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TORC1 signaling and increased lifespan: gained in translation?
Rallis C; Bähler J
Aging (Albany NY); 2013 May; 5(5):335-6. PubMed ID: 23715437
[No Abstract] [Full Text] [Related]
7. Hyperactive mTORC1 signaling is unaffected by metformin treatment in aged skeletal muscle.
Dungan CM; Li Z; Wright DC; Williamson DL
Muscle Nerve; 2016 Jan; 53(1):107-17. PubMed ID: 25926238
[TBL] [Abstract][Full Text] [Related]
8. Investigational drugs and nutrients for human longevity. Recent clinical trials registered in ClinicalTrials.gov and clinicaltrialsregister.eu.
Garay RP
Expert Opin Investig Drugs; 2021 Jul; 30(7):749-758. PubMed ID: 34081543
[No Abstract] [Full Text] [Related]
9. Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer.
Anisimov VN
Aging (Albany NY); 2013 May; 5(5):337-8. PubMed ID: 23715473
[No Abstract] [Full Text] [Related]
10. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
11. Chronic mechanistic target of rapamycin inhibition: preventing cancer to delay aging, or vice versa?
Sharp ZD; Curiel TJ; Livi CB
Interdiscip Top Gerontol; 2013; 38():1-16. PubMed ID: 23503511
[TBL] [Abstract][Full Text] [Related]
12. Koschei the immortal and anti-aging drugs.
Blagosklonny MV
Cell Death Dis; 2014 Dec; 5(12):e1552. PubMed ID: 25476900
[TBL] [Abstract][Full Text] [Related]
13. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
[TBL] [Abstract][Full Text] [Related]
14. Aging and TOR: interwoven in the fabric of life.
Sharp ZD
Cell Mol Life Sci; 2011 Feb; 68(4):587-97. PubMed ID: 20960025
[TBL] [Abstract][Full Text] [Related]
15. mTOR: a pharmacologic target for autophagy regulation.
Kim YC; Guan KL
J Clin Invest; 2015 Jan; 125(1):25-32. PubMed ID: 25654547
[TBL] [Abstract][Full Text] [Related]
16. Gerosuppressant metformin: less is more.
Menendez JA; Cufí S; Oliveras-Ferraros C; Vellon L; Joven J; Vazquez-Martin A
Aging (Albany NY); 2011 Apr; 3(4):348-62. PubMed ID: 21483040
[No Abstract] [Full Text] [Related]
17. Colorectal cancer: elongation is essential.
Seton-Rogers S
Nat Rev Cancer; 2014 Dec; 14(12):764-5. PubMed ID: 25391362
[No Abstract] [Full Text] [Related]
18. Ageing and metabolism: drug discovery opportunities.
Curtis R; Geesaman BJ; DiStefano PS
Nat Rev Drug Discov; 2005 Jul; 4(7):569-80. PubMed ID: 15976816
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
20. Stem-ing mTOR: p53 maintains the male germline.
Payne CJ
Cell Cycle; 2015; 14(20):3218. PubMed ID: 26313854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
